share_log

Adial Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Gilliland Robertson H.

Adial Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities

Adial Pharmaceuticals | 4：持股變動聲明
美股SEC公告 ·  03/28 06:25
牛牛AI助理已提取核心訊息
In a recent transaction dated 03/25/2024, Robertson H. Gilliland, associated with Adial Pharmaceuticals (ADIL.US), was involved in a stock market event. The specific details regarding the nature of the transaction, such as the number of shares traded, the transaction price, and the resulting shareholding, were not disclosed. This event could be of interest to investors following Adial Pharmaceuticals, as insider transactions can provide insights into the company's financial health and future prospects.
In a recent transaction dated 03/25/2024, Robertson H. Gilliland, associated with Adial Pharmaceuticals (ADIL.US), was involved in a stock market event. The specific details regarding the nature of the transaction, such as the number of shares traded, the transaction price, and the resulting shareholding, were not disclosed. This event could be of interest to investors following Adial Pharmaceuticals, as insider transactions can provide insights into the company's financial health and future prospects.
在最近於2024年3月25日進行的一筆交易中，與艾迪爾製藥（ADIL.US）相關的羅伯遜·吉利蘭參與了一次股市事件。有關交易性質的具體細節，例如交易的股票數量、交易價格和由此產生的股權，沒有披露。關注Adial Pharmicals的投資者可能會對這一事件感興趣，因爲內幕交易可以爲公司的財務狀況和未來前景提供見解。
在最近於2024年3月25日進行的一筆交易中，與艾迪爾製藥（ADIL.US）相關的羅伯遜·吉利蘭參與了一次股市事件。有關交易性質的具體細節，例如交易的股票數量、交易價格和由此產生的股權，沒有披露。關注Adial Pharmicals的投資者可能會對這一事件感興趣，因爲內幕交易可以爲公司的財務狀況和未來前景提供見解。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生，只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。